SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000886163-21-000080
Filing Date
2021-06-07
Accepted
2021-06-04 19:48:53
Documents
12
Period of Report
2021-06-04
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K lgnd-20210604.htm   iXBRL 8-K 49681
  Complete submission text file 0000886163-21-000080.txt   186621

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lgnd-20210604.xsd EX-101.SCH 1921
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lgnd-20210604_lab.xml EX-101.LAB 24270
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lgnd-20210604_pre.xml EX-101.PRE 12654
5 EXTRACTED XBRL INSTANCE DOCUMENT lgnd-20210604_htm.xml XML 10786
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33093 | Film No.: 21997917
SIC: 2834 Pharmaceutical Preparations